Systemic inflammation and transcriptional reprogramming contribute to progression to active rheumatoid arthritis in ACPA+ individuals 4474
作者
Mark A. K. Gillespie,Ziyuan He,Pravina Venkatesan,Marla C. Glass,Marie L. Feser,Leander Lazaro,Lauren Y. Okada,Nhung Tran,Yudong D. He,Samir Rachid Zaim,Christy Bennett,Priya Ravisankar,Mary Kristen Demoruelle,Qiuyu Gong,Lucas T. Graybuck,Claire E. Gustafson,Upaasana Krishnan,Kristine A. Kuhn,Julian Reading,Fan Zhang
出处
期刊:Journal of Immunology [American Association of Immunologists] 日期:2025-11-01卷期号:214 (Supplement_1)
Abstract Description Some autoimmune diseases, including rheumatoid arthritis (RA), are preceded by a subclinical phase of disease activity. Proactive clinical management is hampered by a lack of biological understanding of this subclinical ‘at-risk’ state and the changes underlying disease development. In a cross-sectional and longitudinal multi-omics study of peripheral immunity in the autoantibody-positive at-risk for RA period, we identified 275 proteins that differentiated ACPA+ at-risk individuals (ARI) from ACPA- controls. A cluster of ACPA+ donors were found to have an inflammatory protein signature that included elevated IL-1B, VEGFA, CXCL3 and CCL4. This inflammatory signature was accompanied by transcriptional reprogramming across all major immune compartments of ARI, including naive, effector and memory T and B cells. By contrast, in longitudinal samples of ARI who developed clinical RA, the transcriptional response was restricted to naive and central memory (CM) CD4 T cells. We discovered a shared activation signature within naive and CM CD4 T cells during progression to clinical RA, highlighted by reduced expression of CD3 components together with elevated STAT5B, ICOS and AKT3. These progressive changes in naive and CM T cells were the same that were diminished in our independent analyses of a second study of RA patients who responded to CTLA4-Ig therapy. Our findings suggest pathogenesis begins prior to clinical symptoms and suggest approaches for proactive early intervention. Topic Categories Translational and Interventional Immunology (TI)